A Phase 1 study of BMS-986470 in healthy volunteers and sickle cell disease patients
Recruiting Phase 1,Phase 2 NCT06481306
Study Description
A study to evaluate the safety and effectiveness of an investigational drug (BMS-986470) in healthy volunteers and patients with sickle cell disease
Study Details
- Registry ID:
- NCT06481306
- Conditions:
- Anemia, Sickle Cell, Healthy Volunteers
- Phase:
- Phase 1,Phase 2
- Target Enrollment:
- 224 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (51 sites)
-
Local Institution - 0015
Marseille, France -
Local Institution - 0015
Marseille, Bouches-du-Rhône, France -
Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone
Marseille, France -
Local Institution - 0011
Milan, Lombardy, Italy -
Local Institution - 0009
Verona, Italy -
Local Institution - 0037
Padua, Italy -
Local Institution - 0061
Créteil, France -
Hôpital Universitaire Necker Enfants Malades
Paris, France -
Local Institution - 0023
Paris, France -
CHU Strasbourg-Hautepierre
Strasbourg, France -
Institut de cancérologie Strasbourg Europe (ICANS)
Strasbourg, Alsace, France -
Local Institution - 0025
Strasbourg, Alsace, France -
University Hospitals Sussex NHS Foundation Trust
East Sussex, United Kingdom -
Local Institution - 0004
East Sussex, United Kingdom -
Local Institution - 0006
London, London, City Of, United Kingdom -
King's College Hospital
London, London, City of, United Kingdom -
Local Institution - 0044
London, Greater London, United Kingdom -
Local Institution - 0047
London, United Kingdom -
Local Institution - 0005
Leeds, United Kingdom -
Local Institution - 0016
Boston, Massachusetts, United States -
Local Institution - 0024
Boston, Massachusetts, United States -
Boston Medical Center
Boston, Massachusetts, United States -
Local Institution - 0022
New Haven, Connecticut, United States -
Yale-New Haven Hospital
New Haven, Connecticut, United States -
Local Institution - 0029
Philadelphia, Pennsylvania, United States -
Thomas Jefferson University - Medicine/GI and Hepatology
Philadelphia, Pennsylvania, United States -
Local Institution - 0007
Philadelphia, Pennsylvania, United States -
Local Institution - 0033
Greenville, North Carolina, United States -
Virginia Commonwealth University (VCU) Medical Center
Richmond, Virginia, United States -
Local Institution - 0014
Richmond, Virginia, United States -
Local Institution - 0064
Baltimore, Maryland, United States -
Inova Schar Cancer Institute
Fairfax, Virginia, United States -
Local Institution - 0013
Fairfax, Virginia, United States -
Local Institution - 0035
Tampa, Florida, United States -
Local Institution - 0027
Greenville, South Carolina, United States -
Local Institution - 0032
Pittsburgh, Pennsylvania, United States -
Local Institution - 0051
Toronto, Ontario, Canada -
Winship Cancer Institute of Emory University
Atlanta, Georgia, United States -
Local Institution - 0017
Atlanta, Georgia, United States -
Local Institution - 0028
Cleveland, Ohio, United States -
University of Alabama at Birmingham
Birmingham, Alabama, United States -
Local Institution - 0008
Birmingham, Alabama, United States -
Local Institution - 0034
Chicago, Illinois, United States -
Local Institution - 0030
St Louis, Missouri, United States -
ICON
Lenexa, Kansas, United States -
Local Institution - 0001
Lenexa, Kansas, United States -
Local Institution - 0021
La Jolla, California, United States -
University of California San Diego - La Jolla
La Jolla, California, United States -
Local Institution - 0003
Oakland, California, United States -
UCSF Benioff Children's Hospital Oakland
Oakland, California, United States -
Local Institution - 0050
Vancouver, British Columbia, Canada
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.